EcoDrugPlus

Adenosine Receptor A1-Like

Ensembl ID : ENSAMXG00000038612
Gene Symbol: LOC103047745
2 Cross references
210 Possible Orthologues:

Adenosine Receptor A1-Like

Ensembl ID : ENSAMXG00000004314
Gene Symbol: LOC103022025
2 Cross references
208 Possible Orthologues:

Adenosine Receptor A1-Like

Ensembl ID : ENSAMXG00000037152
Gene Symbol: LOC111193686
2 Cross references
214 Possible Orthologues:

Adenosine Receptor A1-Like

Ensembl ID : ENSAMXG00000036826
Gene Symbol: LOC111193665
2 Cross references
214 Possible Orthologues:

Adenosine Receptor A1-Like

Ensembl ID : ENSAMXG00000043733
Gene Symbol: LOC111194551
2 Cross references
210 Possible Orthologues:

Adenosine Receptor A2b

Ensembl ID : ENSAMXG00000013944
Gene Symbol: LOC103021368
3 Cross references
199 Possible Orthologues:

Adenosine Receptor A3-Like

Ensembl ID : ENSAMXG00000036368
Gene Symbol: LOC103047448
3 Cross references
208 Possible Orthologues:

Adhesion Regulating Molecule 1

Ensembl ID : ENSAMXG00000016818
Gene Symbol: ADRM1
3 Cross references
198 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSAMXG00000036757
Gene Symbol: ADRA1B
3 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSAMXG00000040492
Gene Symbol: ADRA1D
4 Cross references
195 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSAMXG00000025613
Gene Symbol: ADRA2A
1 Cross references
176 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSAMXG00000037029
Gene Symbol: ADRA2B
1 Cross references
211 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).